Treatment with SD-101 distributed via pressure-enabled drug delivery with immune checkpoint inhibition was tolerated and resulted in the depletion of Tregs, M-MDSCs, and M2 macrophages in liver metastases in patients with uveal melanoma.
TriSalus Life Sciences® Inc., , an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced.
THURSDAY, Sept. 15, 2022 (HealthDay News) Skin cancer patients appear to fare better if they receive immunotherapy before their cancers are surgically removed, a pair of clinical trials show.
New Treatment Approach Boosts Odds Against 2 Types of Skin Cancer kentuckynewera.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kentuckynewera.com Daily Mail and Mail on Sunday newspapers.
KNOXVILLE, TN, June 30, 2022 (GLOBE NEWSWIRE) Provectus (OTCQB: PVCT) today announced that updated data from the Company’s initial expansion cohort of.